US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Accustem Sciences Inc.

0.2796

+0.01877.17%

Volume:15.57K

Turnover:4.61K

Market Cap:4.49M

PE:-2.40

High:0.3200

Open:0.2609

Low:0.2609

Close:0.2609

52wk High:2.33

52wk Low:0.2609

Shares:16.07M

Float Shares:9.92M

Volume Ratio:125.35

T/O Rate:0.16%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.1163

ROE:-1794.16%

ROA:-72.64%

PB:-1.16

PE(LYR):- -

Loading ...

Overview Company News Filings

Company Profile

Company Name:

Accustem Sciences Inc.

Exchange:

OTCQB

Establishment Date:

2013

Employees:

4

Office Location:

5 Penn Plaza,19th Floor,#1954,New York,New York,United States

Website:

- -

Zip Code:

10001

Phone:

- -

Fax:

- -

Introduction:

AccuStem Sciences, Inc., a clinical stage diagnostics company, focuses on developing and commercializing products for the treatment and management of various cancers. Its primary product candidate is StemPrintER, a 20-gene prognostic assay to predict the risk of distant recurrence in luminal breast cancer patients. The company was founded in 2013 and is headquartered in New York, New York.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/ACUT/company"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ACUT","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ACUT\",,,,,undefined,":{"symbol":"ACUT","market":"US","secType":"STK","nameCN":"Accustem Sciences Inc.","latestPrice":0.279594,"timestamp":1779120300000,"preClose":0.2609,"halted":0,"volume":15573,"delay":15,"changeRate":0.07165197393637404,"floatShares":9922079,"shares":16072267,"eps":-0.1163,"marketStatus":"Trading","change":0.018694,"latestTime":"05-18 12:05:00 EDT Delay","open":0.2609,"high":0.32,"low":0.2609,"amount":4607.2798365,"amplitude":0.226524,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"ttmEps":-0.1163,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1779134400000},"marketStatusCode":2,"adr":0,"exchange":"OTCQB","adjPreClose":0.2609,"volumeRatio":125.346145},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ACUT\",,,,,undefined,":{"symbol":"ACUT","floatShares":9922079,"roa":"-72.64%","roe":"-1794.16%","lyrEps":0,"volumeRatio":125.346145,"shares":16072267,"dividePrice":0,"high":0.32,"amplitude":0.226524,"preClose":0.2609,"low":0.2609,"week52Low":0.2609,"pbRate":"-1.16","week52High":2.33,"institutionHeld":0,"latestPrice":0.279594,"eps":-0.1163,"divideRate":0,"volume":15573,"delay":15,"ttmEps":-0.1163,"open":0.2609,"prevYearClose":0.81351,"prevWeekClose":0.2609,"prevMonthClose":0.28,"prevQuarterClose":0.38,"fiveDayClose":0.2609,"twentyDayClose":0.32,"sixtyDayClose":0.4703},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ACUT\",params:#limit:5,,,undefined,":[{"market":"US","date":"2024-09-16","symbol":"ACUT","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1726459200000,"reportTimeType":"","actualEps":null},{"market":"US","date":"2024-05-20","symbol":"ACUT","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1716177600000,"reportTimeType":"","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ACUT\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ACUT\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":669855648,"yearFounded":2013,"employeeNum":4,"address":"5 Penn Plaza,19th Floor,#1954,New York,New York,United States","zipCode":"10001","fiscalYearEnd":"12-31"},"stockCompanyDetail":{"description":"AccuStem Sciences, Inc., a clinical stage diagnostics company, focuses on developing and commercializing products for the treatment and management of various cancers. Its primary product candidate is StemPrintER, a 20-gene prognostic assay to predict the risk of distant recurrence in luminal breast cancer patients. The company was founded in 2013 and is headquartered in New York, New York.","exchange":"OTCQB","name":"Accustem Sciences Inc.","nameEN":"Accustem Sciences Inc."}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"ACUT\",market:\"US\",,,undefined,":null}}